Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:40:15 2026-05-13 pm EDT			5-day change	1st Jan Change
340.92 ^USD	-3.21%		-2.11%	-9.92%

May. 07	Becton Dickinson raises 2026 profit forecast on drug delivery devices demand	RE
May. 07	Becton Dickinson raises annual profit forecast on strength in drug delivery devices	RE

Tranche Update on Waters Corporation's Equity Buyback Plan announced on January 23, 2019.

Published on 02/23/2026 at 09:10 am EST

S&P Capital IQ

WATERS CORPORATION

-3.21%

From September 28, 2025 to December 31, 2025, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 15,195,844 shares, representing 22.96% for $3,790.62 million under the buyback announced on January 23, 2019.

Latest news about Waters Corporation

May. 07	Becton Dickinson raises 2026 profit forecast on drug delivery devices demand	RE
May. 07	Becton Dickinson raises annual profit forecast on strength in drug delivery devices	RE
May. 06	Deutsche Bank Adjusts Price Target on Waters to $350 From $330	MT
May. 06	UBS Adjusts Price Target on Waters to $375 From $330, Maintains Neutral Rating	MT
May. 06	Analyst recommendations: AMD, KKR, PayPal Holdings, Arista Networks, and TransDigm Group.
May. 06	TD Cowen Adjusts Price Target on Waters to $385 From $345	MT
May. 05	US Equity Markets End Higher as US Says Iran Ceasefire Holds, Oil Falls	MT
May. 05	Waters Corporation, Q1 2026 Earnings Call, May 05, 2026
May. 05	Waters Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026	CI
May. 05	Waters raises annual profit forecast as biosciences unit drives growth	RE
May. 05	Waters Fiscal Q1 Adjusted Earnings, Revenue Increase; 2026 Adjusted EPS Guidance Lifted	MT
May. 05	(WAT) Waters Corporation Expects Q2 Revenue Range $1.62B - $1.63B	MT
May. 05	(WAT) Waters Corporation Expects Q2 Adjusted EPS Range $2.95 - $3.05	MT
May. 05	Earnings Flash (WAT) Waters Corporation Reports Q1 Revenue $1.27B, vs. FactSet Est of $1.20B	MT
May. 05	Earnings Flash (WAT) Waters Corporation Posts Q1 Adjusted EPS $2.70 per Share, vs. FactSet Est of $2.31	MT

Chart Waters Corporation

Duration

Period

WAT: Dynamic Chart

Company Profile

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (62.3%): chromatographic analysis instruments (56% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (30.6%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (13.4%); - services (37.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.1%), industrial (30.7%), academic institutions and governmental agencies (11.2%). Net sales are distributed geographically as follows: the United States (31.6%), Americas (6.2%), China (13.4%), Japan (5.3%), Asia (14%) and Europe (29.5%).

Employees

16,000

Sector

Advanced Medical Equipment & Technology

More about the company